In this final newsletter, I wanted to highlight one of my favorite sources for new research on COVID-19 and Long COVID (and one that published a new paper recently): the Patient-Led Research Collaborative (PLRC). PLRC is a group of people with Long COVID and related chronic diseases, such as ME/CFS and POTS, who also have scientific research experience.
Read MoreSources and updates for the week of October 29 include healthcare worker burnout, an update about viral load, new Long COVID papers, and more.
Read MoreSources and updates for the week of October 22 include new Long COVID papers, hospital-acquired infections, and global wastewater surveillance.
Read MoreDespite impacting millions of people prior to the pandemic, ME/CFS is not well studied; research into the condition is underfunded, and doctors typically don’t learn about it during their training. A new paper from the Rochester Mayo Clinic and ME Action, a ME/CFS advocacy group, may help change this, by offering guidelines for doctors who have patients with this condition.
Read MoreSources and updates for the week of October 15 include local COVID-19 advocacy groups, next-generation vaccines, and Long COVID papers.
Read MoreSources and updates for the week of October 8 include new papers about booster shot uptake, at-home tests, and Long COVID symptoms.
Read MoreScientists are moving closer to biomarkers, or clear biological indicators, of Long COVID. A new study—posted this week in Nature ahead of full publication—identifies clear differences between blood samples of people who have the condition and those who don’t.
Read MoreSources and updates for the week of September 10 include monoclonal antibody costs, viral persistence in Long COVID, and Medicaid unwinding.
Read MoreSources and updates for the week of September 3 include a new CDC updates page, Long COVID research, and people who are more vulnerable to severe COVID-19.
Read MoreSources and updates for the week of August 27 include funding from Project Next Gen, wastewater testing for more viruses, health misinformation, and more.
Read More